Skip to main content

Table 1 TNM classification of DTC patients

From: Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi

 

T1b

T2

T3

T4

Tx

 

N0

N1

Nx

Total

Group A (30 mCi)

13 (15%)

42 (48%)

9 (10%)

0

20 (25%)

86 (100%)

46 (53%)

0

40 (47%)

86 (100%)

Group B (60 mCi)

37 (29%)

59 (46%)

11 (8%)

7 (5%)

14 (10%)

128 (100%)

74 (57%)

5 (4%)

49 (39%)

128 (100%)

Group C (100 mCi)

22 (23%)

50 (52%)

5 (4%)

7 (7%)

13 12(%)

95 (100%)

53 (55%)

13 (14%)

29 (31%)

95 (100%)

Total

72

151

25

14

47

309

173

18

118

309